Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET;ORAL - 200MG
USFDA APPLICATION NUMBER - 21361
DOSAGE - TABLET;ORAL - 550MG
USFDA APPLICATION NUMBER - 21361
Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Coating Systems & Additives
Controlled & Modified Release
Fillers, Diluents & Binders
Disintegrants & Superdisintegrants
Thickeners and Stabilizers
Direct Compression
Film Formers & Plasticizers
Granulation
Co-Processed Excipients
Lubricants & Glidants
Empty Capsules
API Stability Enhancers
Chewable & Orodispersible Aids
Vegetarian Capsules
Taste Masking
Topical
Parenteral
Solubilizers
Emulsifying Agents
Rheology Modifiers
Coloring Agents
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
98
PharmaCompass offers a list of Rifaximin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Rifaximin manufacturer or Rifaximin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rifaximin manufacturer or Rifaximin supplier.
A Glaxo Wellcome brand of rifaximin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Glaxo Wellcome brand of rifaximin, including repackagers and relabelers. The FDA regulates Glaxo Wellcome brand of rifaximin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Glaxo Wellcome brand of rifaximin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Glaxo Wellcome brand of rifaximin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Glaxo Wellcome brand of rifaximin supplier is an individual or a company that provides Glaxo Wellcome brand of rifaximin active pharmaceutical ingredient (API) or Glaxo Wellcome brand of rifaximin finished formulations upon request. The Glaxo Wellcome brand of rifaximin suppliers may include Glaxo Wellcome brand of rifaximin API manufacturers, exporters, distributors and traders.
click here to find a list of Glaxo Wellcome brand of rifaximin suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Glaxo Wellcome brand of rifaximin DMF (Drug Master File) is a document detailing the whole manufacturing process of Glaxo Wellcome brand of rifaximin active pharmaceutical ingredient (API) in detail. Different forms of Glaxo Wellcome brand of rifaximin DMFs exist exist since differing nations have different regulations, such as Glaxo Wellcome brand of rifaximin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Glaxo Wellcome brand of rifaximin DMF submitted to regulatory agencies in the US is known as a USDMF. Glaxo Wellcome brand of rifaximin USDMF includes data on Glaxo Wellcome brand of rifaximin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Glaxo Wellcome brand of rifaximin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Glaxo Wellcome brand of rifaximin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Glaxo Wellcome brand of rifaximin Drug Master File in Japan (Glaxo Wellcome brand of rifaximin JDMF) empowers Glaxo Wellcome brand of rifaximin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Glaxo Wellcome brand of rifaximin JDMF during the approval evaluation for pharmaceutical products. At the time of Glaxo Wellcome brand of rifaximin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Glaxo Wellcome brand of rifaximin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Glaxo Wellcome brand of rifaximin Drug Master File in Korea (Glaxo Wellcome brand of rifaximin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Glaxo Wellcome brand of rifaximin. The MFDS reviews the Glaxo Wellcome brand of rifaximin KDMF as part of the drug registration process and uses the information provided in the Glaxo Wellcome brand of rifaximin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Glaxo Wellcome brand of rifaximin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Glaxo Wellcome brand of rifaximin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Glaxo Wellcome brand of rifaximin suppliers with KDMF on PharmaCompass.
A Glaxo Wellcome brand of rifaximin CEP of the European Pharmacopoeia monograph is often referred to as a Glaxo Wellcome brand of rifaximin Certificate of Suitability (COS). The purpose of a Glaxo Wellcome brand of rifaximin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Glaxo Wellcome brand of rifaximin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Glaxo Wellcome brand of rifaximin to their clients by showing that a Glaxo Wellcome brand of rifaximin CEP has been issued for it. The manufacturer submits a Glaxo Wellcome brand of rifaximin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Glaxo Wellcome brand of rifaximin CEP holder for the record. Additionally, the data presented in the Glaxo Wellcome brand of rifaximin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Glaxo Wellcome brand of rifaximin DMF.
A Glaxo Wellcome brand of rifaximin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Glaxo Wellcome brand of rifaximin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Glaxo Wellcome brand of rifaximin suppliers with CEP (COS) on PharmaCompass.
A Glaxo Wellcome brand of rifaximin written confirmation (Glaxo Wellcome brand of rifaximin WC) is an official document issued by a regulatory agency to a Glaxo Wellcome brand of rifaximin manufacturer, verifying that the manufacturing facility of a Glaxo Wellcome brand of rifaximin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Glaxo Wellcome brand of rifaximin APIs or Glaxo Wellcome brand of rifaximin finished pharmaceutical products to another nation, regulatory agencies frequently require a Glaxo Wellcome brand of rifaximin WC (written confirmation) as part of the regulatory process.
click here to find a list of Glaxo Wellcome brand of rifaximin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Glaxo Wellcome brand of rifaximin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Glaxo Wellcome brand of rifaximin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Glaxo Wellcome brand of rifaximin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Glaxo Wellcome brand of rifaximin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Glaxo Wellcome brand of rifaximin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Glaxo Wellcome brand of rifaximin suppliers with NDC on PharmaCompass.
Glaxo Wellcome brand of rifaximin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Glaxo Wellcome brand of rifaximin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Glaxo Wellcome brand of rifaximin GMP manufacturer or Glaxo Wellcome brand of rifaximin GMP API supplier for your needs.
A Glaxo Wellcome brand of rifaximin CoA (Certificate of Analysis) is a formal document that attests to Glaxo Wellcome brand of rifaximin's compliance with Glaxo Wellcome brand of rifaximin specifications and serves as a tool for batch-level quality control.
Glaxo Wellcome brand of rifaximin CoA mostly includes findings from lab analyses of a specific batch. For each Glaxo Wellcome brand of rifaximin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Glaxo Wellcome brand of rifaximin may be tested according to a variety of international standards, such as European Pharmacopoeia (Glaxo Wellcome brand of rifaximin EP), Glaxo Wellcome brand of rifaximin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Glaxo Wellcome brand of rifaximin USP).
